PP01.123: A Global Phase 3, Double-Blind, Randomized Trial of Pumitamig (BNT327/BMS986545; PD-L1 × VEGF-A bsAb) Plus Chemotherapy Compared to Atezolizumab Plus Chemotherapy in Patients with First-Line (1L) Extensive-Stage Small Cell Lung Cancer (ES-SCLC) - ROSETTA Lung-01

平台已收录预计检索 <10 秒

查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。

文献信息

题目: PP01.123: A Global Phase 3, Double-Blind, Randomized Trial of Pumitamig (BNT327/BMS986545; PD-L1 × VEGF-A bsAb) Plus Chemotherapy Compared to Atezolizumab Plus Chemotherapy in Patients with First-Line (1L) Extensive-Stage Small Cell Lung Cancer (ES-SCLC) - ROSETTA Lung-01
作者: Martin Reck, John Heymach, Kevin Franks, Carl Gay, Vinod Ganju, Ina Nordman, Nicolas Girard, Mehmet Ali Nahit Sendur, Ilhan Celik, Isaac Dai, Secil Koseoglu, Sarita Koride, Karrie Wang, Silke Günther, Özlem Türeci, Ugur Sahin
发表年份: 2026
期刊 / 来源: Journal of Thoracic Oncology
出版社: Elsevier
DOI: 10.1016/j.jtho.2026.103857
文献类型: 学术文献
平台记录更新: 2026-08-31 18:28:24

本页由 Scihuhuan.com 学术互换提供文献检索、引用与获取指引；论文版权和出版身份归原出版方。